Research

Research Funding Opportunities

Core Research Essay Prize 2016

core

Core is offering a £1,000 award for the best essay based on gastroenterology or hepatology research undertaken by a clinical or basic science researcher during their MD or PhD. The work must be the subject of at least one abstract submitted for presentation at the 2016 British Society of Gastroenterology Annual Meeting in Liverpool. Further information and the application form are available to download. The closing date is 4 March 2016.


Dr Falk Pharma / Core Awards 2016

core

The Dr Falk/Core awards recognise those who bring new knowledge and insight to the field of gastroenterology and hepatology. For those committed to furthering research or patient care, the 2016 awards are an opportunity to achieve national recognition as well as the financial support to take your career further.

This year's prizes consist of the following:

  • A £1000 prize for the best essay on gastroenterology research personally undertaken by medical students who were on an intercalated BSc/MRes/MSc/MPH/MBPhD* course during the previous academic year (2014/2015) - download the application
  • Four £1500 bursaries for medical students taking full-time science degrees (BSc/MRes/MSc/MPH/MBPhD*) focusing on gastrointestinal or liver-related disease in the current academic year (2015/2016) - download the application
  • Two £2500 bursaries to support research for F1/F2 doctors who are undertaking research in an area relevant to gastroenterology - download the application
  • A £1,000 award for primary and secondary care nurses for initiatives that have advanced patient care - download the application.

*PhD students should note that they may apply for a bursary only once during their three-year studentship and that they may apply for the essay prize when their PhD has been completed.

The application deadline is 17:00 on Friday 4 March 2016. Applications received after this time will not be considered.


Core BSG Trainee Research Awards

Core and the British Society of Gastroenterology are inviting applications under this new research programme which is open to UK-based trainees.

There are two confirmed deadlines in 2016. Up to two awards of up to £5,000 each will be made per funding round.

The deadlines are:

  • March 31
  • July 29

The research project must address an area of clinical need within gastroenterology and have clear patient benefit. The project must be entirely based within the UK.

It is possible to apply as an individual or as a group (for example as collaborators within a Trainee Research Network) but you must have the agreement of a supervisor who must sign your application.

All relevant non-capital project costs can be funded under this award. This can include, for example, project-related travel or volunteers expenses but excludes conference attendance. Core supported projects are eligible for CRN support.

The successful project should be able to start promptly and a final report should be available to Core within three months of completion. In order to assist with project start-up up to 20% of the grant award can be made in advance. The final 20% of the award will be paid upon receipt of a satisfactory final report and invoice detailing expenditure.

For more information and to download an application form visit http://www.corecharity.org.uk/support-for-researchers/core-bsg-trainee-research-grants/


HS&DR researcher-led funding opportunity 16/01 - standard outline proposal

The HS&DR programme funds research to improve the quality, effectiveness and accessibility of the NHS, including evaluations of how the NHS might improve delivery of services. The audience for this research is the public, service users, clinicians and managers. The specification document and the guidance notes are available with further details on the funder's website. Deadline for applications is 1pm on 14 April 2016.


HS&DR researcher-led funding opportunity 16/02 - evidence synthesis full proposal

The HS&DR programme funds research to improve the quality, effectiveness and accessibility of the NHS, including evaluations of how the NHS might improve delivery of services. The audience for this research is the public, service users, clinicians and managers. The specification document and the guidance notes are available with further details on the funder's website. Deadline for applications is 1pm on 14 April 2016.


Cancer care research funding available: applications open for ECMC status in 2017-22

The ECMC initiative is jointly funded by Cancer Research UK, the NIHR in England and the Departments of Health for Scotland, Wales and Northern Ireland. The ECMC Network strives to push the boundaries of cancer care, by delivering novel and personalised treatments that target a wide range of cancer types across both adult and paediatric specialties. Existing ECMC locations are invited to apply for status for the 2017-22 period, and continue their contribution to a leading Network of early-phase clinical trials. Any location that is not currently an ECMC and wishes to apply for ECMC status must first fill in an Expression of Interest (EoI). Deadline for proposals is Monday 15 August 2016 and you can find out more here.


Cancer Research UK, BUPA Foundation Fund innovation grant: instant seed-funding for cancer prevention research

The BUPA Foundation Fund aims to catalyse new multidisciplinary collaborations and develop innovative research in cancer prevention via sandpit workshops. Innovation workshops will deliver a unique approach to funding population research. Over three days, participants explore cancer challenges, build new collaborations and develop and pitch innovative research ideas that have the potential to be awarded seed funding on the spot. Applications from all disciplines, including investigators across academic, industry and technology sectors are welcomed. The BUPA Foundation Fund would like a broad mix of experts to attend, such as psychologies, epidemiologists, healthcare professionals, engineers, community representatives, and those working in the digital and technology industries. The next workshop, focused around cancer prevention, will take place on 11 – 13 April 2016. Individuals are not expected to come to the event with a pre-formed research idea, as these will be developed over the three days. Deadline for proposals is Monday 29 February 2016.


CRUK Clinician Scientist Fellowship

Career level: Post doc/Clinician/Health professional

Preliminary submission: 23 May 2016
Final submission: 22 August 2016
Committee review: November 2016

Funding period: 5 years
Funding amount: The Fellow's salary and associated running expenses

Fellowships must be hosted in a UK University or research institute. We will consider requests to undertake research outside the UK for a period of the fellowship.


CRUK Advanced Clinician Scientist Fellowship

Career level: Clinician/Post doc/Early career researcher/Health professional

Preliminary submission: 23 May 2016 Final submission: 22 August 2016 Committee review: November 2016

Funding period: 5 years
Funding amount: Salaries and associated running expenses for the Fellow, one postdoctoral researcher and one research technician

This Fellowship offers excellent clinician scientists the opportunity to develop independence and leadership in their field of academic research.

Fellowships must be hosted in a UK university or research institute. Short periods of research experience away from the host institution may be requested and must be fully justified.


CRUK Postdoctoral Research Bursary for Clinical Trainees

Career level: Clinician/Post doc/Early career researcher/Health professional

Final submission: 8 March 2016
Committee review: May 2016

Funding period: up to 2 years
Funding amount: up to £35,000

This award offers funding for clinical trainees to undertake a research project after completion of a PhD.

Fellowships must be hosted in a UK University or research institute. Periods of research experience away from the host institution may be requested and must be fully justified.


MRC Career Development Awards

The Medical Research Council invites applications for its career development award. This supports postdoctoral researchers who are not clinically active to consolidate their research skills and make the transition from postdoctoral researcher to independent investigator. Proposals are encouraged across all areas of Research Council's remit. Applications may range from basic studies with relevance to mechanisms of disease to translational and clinical research. Closing date is 27 April 2016.


MRC Senior Clinical Fellowships

The Medical Research Council invites applications for its senior clinical fellowships. These support medically and other clinically qualified professionals, with an effective track record of internationally competitive independent research, to make the transition to research leadership. Applications are welcome across all areas of MRC’s remit and may range from basic studies with relevance to mechanisms of disease to translational and developmental clinical research. Closing date is 6 April 2016.


MRC Clinical Science Fellowships

The CSF develops talented medically and other clinically qualified professionals who have gained a higher research degree to lead their own research plans and establish their own research team to make the transition to independent investigator. Applications are invited for the standard CSFs, the Tenure Track CSFs, or the jointly funded CSFs, all of which are considered in open competition. Closing date is 6 April 2016.


Wellcome Trust Sir Henry Dale Fellowships

These fellowships are for outstanding postdoctoral scientists wishing to build their own UK-based independent research career addressing an important biomedical question. Research can range from the molecules and cells vital to life and their role in the global spread of disease, to clinical and public health research seeking to improve the quality of healthcare. It can be based in the laboratory, clinic or field, and may involve experimental or theoretical approaches. Closing date is 12 April 2016.


Wellcome Trust Research Training Fellowships

The Wellcome Trust invites applications for its research training fellowships. These support medical, dental, veterinary or clinical psychology graduates who wish to develop a long-term career in academic medicine. The scheme enables individuals to undertake substantial training towards a PhD or MD qualification through high-quality research in an appropriate unit or clinical research facility. Closing date: 4 April 2016.


Pancreatic Cancer Research Fund

The Pancreatic Cancer Research Fund invites applications for its research grant, which supports translational research in the field of pancreatic cancer, with a particular focus on early detection and successful treatment. Closing date is 13 April 2016 (forecast). Further information can be obtained here.


Worldwide Cancer Research GB Project Grants

Worldwide Cancer Research invites applications for its project grants, which support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. The closing date is 29 April 2016. Further information can be obtained here.


MRC rapid response funding - Zika virus

To better understand the nature of the risk posed by the Zika virus, the Medical Research Council (MRC) is launching a £1m rapid response funding initiative. Details are available from the MRC. The application deadline is 12 noon on 22 February 2016.


Liver and GI Theme Cohort Development Grants Call

Background: The Rare Diseases Translational Research Consortium (RD-TRC) has been established to support the development of world-leading, deep-phenotyped patient cohorts in rare diseases (defined as a population prevalence of <50/100,000). The intention is both to support research into the causes and mechanisms of rare diseases and to facilitate translational and therapeutics research, in particular through collaboration with industry partners. RD-TRC projects have to be led from within the NIHR infrastructure (Biomedical Research Centres (BRCs) and Biomedical Research Units (BRUs)). There is currently a competition for award of the next generation of BRCs and, following the commencement of the BRC 5-year funding period, it is likely that there will be a new national RD-TRC competition to fund full cohort development in late 2017.

Current call: The Liver and GI theme (led by the Newcastle BRC) recognises that, to be in a position to compete effectively in the national competition (which will be an open one, with all disease areas in competition with each other), consortia need to do preparatory and underpinning work in order to demonstrate a high likelihood of success if awarded full scale RD-TRC funding. We are very keen to have as many successful RD-TRC grants in Liver and GI as we can (for the benefit of the Liver and GI research and patient communities) and are therefore intending to award up to two £5000 Cohort Development Grants to run up until 31st March 2017. The awards are flexible in nature and may be used as deemed appropriate by successful consortia to support their development (subject to interim and final reporting). Successful consortia will have the support of the theme leaders to make a full bid if the anticipated call happens.

RD-TRC is designed to encourage and facilitate industry investment, and NIHR policy is to place a high priority on Patient and Public Involvement, and requires patient/NHS or societal benefit within 5 years of funding. Evidence that these aspirations/criteria will be met will be essential for bids to be successful. Note that NIHR will not support any animal-based research.

Process: Interested consortia are requested to register their interest as soon as possible with This e-mail address is being protected from spambots. You need JavaScript enabled to view it and complete and send the form by 29th February 2016 to This e-mail address is being protected from spambots. You need JavaScript enabled to view it . Questions about the scheme, including relevance and eligibility of the disease area, are welcome ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ). Note that, although an outline of the proposed spend is required, detailed costings are not required at this stage.


Prevention and treatment of obesity: NIHR themed call

The NIHR has issued a call for research into the evaluation of interventions or services for the prevention and treatment of obesity in adults and children. Issues of particular importance for this call include the prevention of type 2 diabetes and increasing levels of physical activity. Preventing obesity and type 2 diabetes is a priority for the UK Government. With over 60% of the adult population either overweight or obese and more than 2.7 million people diagnosed with type 2 diabetes, the health burden and economic impact of obesity in the UK are increasing. This call is an initiative by the NIHR in recognition of the need for further research-based evidence to underpin the prevention and management of overweight and obesity in adults and children.

You must apply through one of the participating NIHR programmes by the relevant deadline. Some of the participating programmes will accept also applications later in 2016; the deadlines will be updated once these dates are confirmed.

Please read the specification document: the prevention and treatment of obesity before starting your application, and make use of the help with applying section of the website.


Biomedical Research Centres Competition

A new, open competition for NIHR Biomedical Research Centre (BRC) funding has been launched. NHS organisations in England, in collaboration with their University partner, are invited to submit a Pre-qualifying Questionnaire (PQQ) for consideration for NIHR BRC designation and funding. All applications will be reviewed by an independent International Selection Panel who will make recommendations on Biomedical Research Centre designation and funding.

The NIHR BRCs will be funded to support people- and/or patient-focused early translational (experimental medicine) research, the aim of which is to translate discoveries from basic/discovery science into clinical research, and through to benefits for patients, the health system and for broader economic gain.

The scheme aims to provide NIHR BRC funding for NHS/University partnerships in England that have a very substantial portfolio of world-class biomedical research across either a range of clinical or research areas, or in a specific clinical or research area. In all cases NIHR BRCs will contain substantial existing critical mass, a significant number of researcher leaders, and a wide range of underpinning facilities.

Funding to the NHS partner is over a five year period, from 1 April 2017 to 31 March 2022. The closing date for submission of pre-qualifying questionnaires (PQQ) by NHS/University partnerships that are interested in being considered for an NIHR BRC is 15 February 2016 at 13:00. An FAQ document has been published and will be regularly updated as additional questions on the competition are received. For more information, see the invitation to submit PQQ guidance document.


NIHR Programme Development Grants - Invitation for Applications for Competition 15

Programme Development Grants are designed to increase the rate and number of successful applications for a full Programme Grant by supporting the completion of the necessary preparatory work to suitably position the research team to submit a competitive Stage 2 Programme Grant application. Awards are for a maximum of £100k over a maximum period of 18 months. The application deadline is 8 March 2016 at 13:00. Read more and apply.


Proposed research areas for HTA commissioned calls - updated 10 February 2016

The HTA Programme will announce proposed topic areas for future commissioned research in mid February 2016. Please also note that topic areas and timings are subject to change. The individual commissioning briefs, which will be published when the call opens, will define the details of the call.


Inflammation EUROPE ASPIRE 2016 Research Awards

Pfizer is proud to support the Inflammation EUROPE ASPIRE 2016 Research Awards, a competitive grants programme for investigators in Europe. This programme provides research grants (€60,000 each) for studies designed and conducted by non-Pfizer physicians and scientists. To be eligible for an investigator award, an applicant must hold an MD, PhD, PharmD or the equivalent and must reside in wider Europe, including Israel, Russia and Turkey.

Applicants should submit research proposals with the primary objective of further understanding:

  • The role of the JAK–STAT pathways in immune-mediated inflammatory diseases with a focus on rheumatoid arthritis (RA) or ulcerative colitis (UC). Proposals in psoriasis and psoriatic arthritis are also of interest
  • The effect of specific inhibition of the JAK–STAT pathways by targeting JAK on specific clinical effects, looking at efficacy and/or safety outcomes

An independent external review committee consisting of European medical and scientific experts will review the research proposals and select the grant recipients. Please go to the programme's website and review the summary PDF for further information on the programme. The application deadline is 29 February 2016.


£10,000 forCrohn's Innovation Grant

forCrohns is the UK's only charity solely dedicated to Crohn's disease. Their mission is to fund research that helps those with the condition today and contributes to finding a cure for Crohn's disease in the future whilst making more people in the UK aware of the disease and its symptoms. Last year they funded approximately £80,000 of basic science and clinical research in various specialist institutions.They have also now created a new Innovation Grant to focus more on the shorter term.

Aim

The aim of the Innovation Grant is to support gastroenterology healthcare professionals to find new ways to immediately improve the lives of patients with Crohn's disease.

Funding

forCrohns new innovation grant will be used to fund projects that demonstrate a clear and immediate benefit for Crohn's disease patients. Up to £10,000 will be awarded to successful applicants. The application process is open from 1 January 2016 – 10 March 2016.

Criteria of Grant

All projects must meet the following criteria and will be judged against them:

  • An outcome which demonstrates a clear and immediate benefit for Crohn's patients (Whilst it is appreciated that many projects may have a dual benefit for those with UC, the charity's main aim is focused on the output for Crohn's)
  • A short expected time between study and implementation
  • Robust assessment of outcomes
  • Potential to scale nationally for pilot projects

For more information about the Innovation Grant and to download an application form, please go to http://bit.ly/forcrohnsinnovation


NIHR Programme Grants for Applied Research - Competition 20

Programme Grants aim to produce independent research findings that will have practical application for the benefit of patients and the NHS in the relatively near future. Programme Development Grants are a complementary scheme to allow investigators to undertake preparatory research that will position them to submit a competitive Programme Grant application. The deadline for submission of Stage 1 applications is 6 April 2016. Research funded through a Programme Grant typically consists of an interrelated group of high quality projects focused on a coherent theme. The projects will therefore require multidisciplinary approaches, including clinical, health economics, statistics, qualitative and behavioural sciences, to ensure that research objectives can be met. The amount awarded and the length of the funding period will depend on the nature of the proposed work, in particular whether or not the proposal includes a substantial powered trial. Programme Grants will now launch three Competitions per year, with Stage 1 opening for applications in February, June and October. Please see the call schedule on the PDG Calls and Competitions page for further details.


EME funding opportunity 15/176 - Delirium

This is a call for science-driven applications to investigate the efficacy of interventions in the prevention or treatment of acute, time-limited delirium, including the use of novel or repurposed therapeutic agents. Applications that explore the mechanisms underlying the effects of the intervention or the delirium itself are encouraged. This call does not seek applications for the treatment of the specific conditions that may be the precipitating cause for the onset of delirium, e.g. the onset of an infection. Applications must concentrate on determining the clinical efficacy of interventions, but the inclusion of embedded hypothesis-driven mechanistic studies within the main clinical evaluation is strongly encouraged. Applications may investigate novel or repurposed interventions and technologies. Studies of incremental or minor improvements to existing technologies or discovery of new biomarkers are not within the remit of the EME programme. Projects must have a strong collaborative approach, involving at least two of academia, NHS and industry. The EME Programme is particularly keen to encourage collaboration with small and medium enterprises.

Please see the commissioning brief for details. The call closes at 1pm on 15 March 2016.


EME funding opportunity 15/177 - Graft versus host disease

This call is for proposals for research into the efficacy of interventions for the prevention, diagnosis or management of graft-versus-host disease. EME would be particularly supportive of multi-arm studies testing a range of novel treatments and the mechanisms underlying the effects of the intervention. Please see the commissioning brief and guidance notes for more information. The call closes at 1pm on 15 March 2016.


EME funding opportunity 15/178 - Use of cell therapies

Proposals are invited for studies into the use of cell therapies for the treatment of disease in adults and children. Proposals should describe translational cell therapy research that investigates the clinical efficacy of the treatment and has the potential to generate new knowledge, which could be used in the future clinical care of patients.

Proposals for use of cell therapies in neurological and ophthalmic conditions are particularly welcome.

Cell transplantation and cell rescue therapies for cancer treatment are not part of this call, unless using genetically modified cells.

Proposals that include embedded mechanistic studies within the main clinical evaluation are strongly encouraged.

Applicants should note that work on animals is not within the remit of the programme. Studies of incremental or minor improvements to existing technologies or discovery of new biomarkers are not within the remit of the EME programme. Projects must have a strong collaborative approach, involving at least two of academia, NHS and industry. The EME Programme is particularly keen to encourage collaboration with small and medium enterprises. Where appropriate, we encourage applicants to engage with the Cell Therapy Catapult as a source of expertise in this area.

Please see the commissioning brief and the guidance notes for further details. The call closes at 1pm on 15 March 2016.


EME funding opportunity 15/75 is now 15/179 - Mechanisms of action of health interventions

Proposals are sought for translational research into the underlying mechanisms of action of clinical and public health interventions. Studies must utilise patients or samples from current or completed NIHR-funded or NIHR-managed studies in any setting. Proposals will be accepted across a wide range of interventions, including behavioural, pharmaceutical, psychological, surgical and public health interventions. The research should be relevant to the intervention and outcomes proposed by the original study and add significantly to the scientific understanding of the mechanisms of action of the intervention.

The proposed research may involve the analysis or reanalysis of previously stored specimens or data, or the collection of new specimens or new data for additional analysis, provided it is obtained from study participants. Discovery of new biomarkers is not within the remit of the EME Programme.

Applicants will need to make a strong case for how a better understanding of the mechanisms of action will potentially contribute to the future use or development of the technology, future wealth creation and for the ultimate benefit of individual patients’ or the wider NHS.

Further details of the commissioning brief are available to download, along with the guidance notes. The deadline for applications has been extended to 15 March 2016 at 1pm.


Proposed research areas for 2016 EME commissioned calls - updated 10 February 2016

Research in the following broad areas is likely to be commissioned during the next year, although the titles and timings may be subject to change. The individual commissioning briefs, which will be published when the calls open, will define the details of the calls.

  • Foetal and maternal health outcomes in chronic diseases: anticipated opening date TBC
  • Clinical efficacy of novel biosensing technologies: anticipated opening date TBC

EME researcher-led funding opportunity 15/180 - 16 November 2015

The EME Programme's researcher-led workstream is an ongoing research funding opportunity funded by the Medical Research Council. You are welcome to submit a preliminary application at any time; however, there will be three cut-off dates each year. The next deadline is 1pm on 15 March 2016. Further information is available from the EME website.


HTA researcher-led funding opportunities - updated 8 December 2015

The researcher-led workstream welcomes proposals on topics or research questions identified by researchers within the programme’s remit. The HTA can verify this for you if you complete and submit a remit check form. The deadlines for the next rounds are Friday 8 April 2016 or Thursday 5 May 2016 (depending on application type), Wednesday 10 August 2016 and Wednesday 30 November 2016. Details can be found on the HTA website.


Graham Bull Prize 2016

The Graham Bull prize was established in 1988 in honour of Sir Graham Bull, who was the first director of the Clinical Research Centre at Northwick Park. A trust for the Graham Bull Prize was set up to provide money for young research workers under the age of 45 who feel that they have made a major contribution to clinical science. The prize as designed by the trust is specifically for an application and not for nomination of individuals. The work can cover a wide range of expertise, such as molecular and cellular biology, imaging technology, psychiatry, or health sciences. The award is open to RCP members and fellows who must apply for their own work to be considered. The sum of £1,000 is offered on a competitive basis each year.

The winner of this prize will also be invited to deliver the Goulstonian Lecture, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband, Dr Theodore Goulston FRCP.

Restrictions

Researchers must be under the age of 45 years on 1 April 2016, and must be a member or fellow of RCP London.

How to apply

The 2016 round closes on 1 April 2016. For more information on this award please email the Funding and Awards administrator: This e-mail address is being protected from spambots. You need JavaScript enabled to view it


The Crohn's in Childhood Research Association offers the following bursaries:

Bursary grants of up to £400 (up to a total amount of £5,000pa) to enable UK based young doctors still in training/nurses/final year medical students and similar persons with an interest in the area of Crohn's and colitis (IBD) to support attendance at national, international scientific/educational congresses and if considered appropriate IBD related training courses. Also a £1000 annual bursary for travel/registration at national and international meetings for doctors in training to become paediatric gastroenterologists.

Application forms and further information can be obtained from the CICRA website: http://www.cicra.org/what-we-do/research/grant-applications


MRC Biochemical Catalyst: Developmental Pathway Funding Scheme - reminder

The DPFS scheme is a key part of the MRC's Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies. DPFS is an ongoing scheme, with outline deadlines every 4 months. The next two deadlines for outline proposals are 4pm on 29 March 2016 and 4pm 27 July 2016. Further details, including the deadlines for the next four calls, can be found on the submission deadlines page for the scheme.

Please note that full submissions to DPFS are by invitation only; submission to the full call is contingent upon prior submission and shortlisting of an outline proposal. Further details are available from the MRC website.


Pump prime funding for initial feasibility studies

NIHR Enteric HTC aims to identify and address unmet clinical need in the diagnosis and management of disorders of the gastrointestinal tract and bowel function. The HTC seeks new ideas for medical device innovations and offers the opportunity to apply to NIHR Enteric HTC for pump prime funding for initial feasibility studies on potential new medical technologies within the field of digestive diseases and GI surgery.